Sernova Biotherapeutics (FRA:PSH0) OCF Margin %: 0.00% (As of Apr. 2026)


FRA:PSH0 Sernova Biotherapeutics Inc FRA:PSH0
27 GF Score
Price €0.09
! 2 Warning Signs
View Full Analysis

What is Sernova Biotherapeutics OCF Margin %?

Sernova Biotherapeutics FRA:PSH0 -6.00% 27 OCF Margin % is 0.00% as of Apr. 2026. GuruFocus rates FRA:PSH0 with a GF Score™ of 27/100. The stock has 2 warning signs investors should review. Among 960 Biotechnology companies, Sernova Biotherapeutics ranks worse than 104166.56% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Sernova Biotherapeutics's Cash Flow from Operations for the three months ended in Apr. 2026 was €-1.37 Mil. Sernova Biotherapeutics's Revenue for the three months ended in Apr. 2026 was €0.00 Mil. Therefore, Sernova Biotherapeutics's OCF Margin % for the quarter that ended in Apr. 2026 was 0.00%.

As of today, Sernova Biotherapeutics's current OCF Yield % is -10.40%.

The historical rank and industry rank for Sernova Biotherapeutics's OCF Margin % or its related term are showing as below:


FRA:PSH0's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -68.59
* Ranked among companies with meaningful OCF Margin % only.

Sernova Biotherapeutics OCF Margin % Related Terms

Sernova Biotherapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Sernova Biotherapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sernova Biotherapeutics OCF Margin % Chart

Sernova Biotherapeutics Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sernova Biotherapeutics Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:PSH0
27GF Score
Sernova Biotherapeutics Inc FRA:PSH0
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sernova Biotherapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Sernova Biotherapeutics's OCF Margin for the fiscal year that ended in Oct. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Oct. 2025 )/Revenue (A: Oct. 2025 )
=-6.699/0
= %

Sernova Biotherapeutics's OCF Margin for the quarter that ended in Apr. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Apr. 2026 )/Revenue (Q: Apr. 2026 )
=-1.373/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Sernova Biotherapeutics (FRA:PSH0) has a OCF Margin % of 0.00% as of Apr. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Sernova Biotherapeutics and its competitors. According to the industry distribution chart, Sernova Biotherapeutics ranks #999999 out of 960 companies in the Biotechnology industry.
Is Sernova Biotherapeutics' OCF Margin % too high?
Sernova Biotherapeutics' current OCF Margin % is 0.00%. Based on the distribution chart, Sernova Biotherapeutics ranks #999999 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Sernova Biotherapeutics has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Sernova Biotherapeutics' OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sernova Biotherapeutics ranks #999999 out of 960 companies for OCF Margin %. This places Sernova Biotherapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Sernova Biotherapeutics and its competitors. Sernova Biotherapeutics's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sernova Biotherapeutics stock overvalued right now?
Sernova Biotherapeutics (FRA:PSH0) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Sernova Biotherapeutics' overall GF Score™ is 27/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Sernova Biotherapeutics (FRA:PSH0), the current OCF Margin % is 0.00% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sernova Biotherapeutics Business Description

Other Exchanges SEOVF:USASVA:Canada
Address RPO Central Parkway, PO Box 29592, Mississauga, ON, CAN, L5A 4H2
Sernova Biotherapeutics Inc is a clinical-stage biotechnology company focused on advancing regenerative medicine for the treatment of chronic diseases. The Company's primary asset is its proprietary Cell Pouch, a bio-hybrid organ system designed to enhance the delivery of cell therapy by replicating natural body functions. The Cell Pouch creates a vascularized, organ-like environment that promotes the longevity and functionality of therapeutic cells and ensures containment for retrievability.
27GF Score

Get the complete analysis for FRA:PSH0

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.09
Price